Bernhard Uehleke

Pharmacokinetics and Bioavailability of Quercetin Glycosides in Humans

E.U. Graefe, Joerg Wittig, Silke Mueller et al. · The Journal of Clinical Pharmacology · 2001 · 611 citations

Hyperforin content determines the magnitude of the St John's wort–cyclosporine drug interaction

Ingrid Mai, Steffen Bauer, Elke S. Perloff et al. · Clinical Pharmacology & Therapeutics · 2004 · 139 citations

The extent of induction of CYP3A by St. John’s wort varies among products and is linked to hyperforin dose

Silke Mueller, J. Majcher‐Peszynska, Bernhard Uehleke et al. · European Journal of Clinical Pharmacology · 2005 · 117 citations

Molecular Pharmacology, St. John ’, Medicine +3

A Research Roadmap for Complementary and Alternative Medicine - What We Need to Know by 2020

Felix Fischer, George Lewith, Claudia M. Witt et al. · Forschende Komplementärmedizin / Research in Complementary Medicine · 2014 · 62 citations · Full text

No clinically relevant CYP3A induction after St. John’s wort with low hyperforin content in healthy volunteers

Silke Mueller, J. Majcher‐Peszynska, Ralf G. Mundkowski et al. · European Journal of Clinical Pharmacology · 2008 · 61 citations · Full text

Healthy Volunteers, Pathology, Low Hyperforin Content +2